Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Sagimet Biosciences Inc shares valued at $74,830 were sold by Kemble George on Jul 23 ’24. At $3.17 per share, Kemble George sold 23,625 shares. The insider’s holdings dropped to 118,693 shares worth approximately $0.53 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Martins Eduardo Bruno sold 8,357 shares, netting a total of over 25,910 in proceeds. Following the sale of shares at $3.10 each, the insider now holds 81,213 shares.
Before that, Rozek Elizabeth had sold 10,914 shares from its account. In a trade valued at $33,830, the General Counsel and CCO traded Sagimet Biosciences Inc shares for $3.10 each. Upon closing the transaction, the insider’s holdings decreased to 10,914 shares, worth approximately $0.72 million.
As published in their initiating research note from UBS on November 12, 2024, Sagimet Biosciences Inc [SGMT] has been a Buy and the price target has been revised to $12. Analysts at Goldman downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in late June. As of May 02, 2024, H.C. Wainwright has initiated its “Buy” rating for SGMT. Earlier on March 25, 2024, Leerink Partners initiated its rating. Their recommendation was “an Outperform” for SGMT stock.
Analyzing SGMT Stock Performance
During the last five days, there has been a drop of approximately -13.13%. Over the course of the year, Sagimet Biosciences Inc shares have dropped approximately -16.97%. Shares of the company reached a 52-week high of $20.71 on 01/22/24 and a 52-week low of $2.39 on 08/14/24. A 50-day SMA is recorded $4.60, while a 200-day SMA reached $4.45. Nevertheless, trading volume fell to 0.5 million shares from 0.26 million shares the previous day.
Support And Resistance Levels for Sagimet Biosciences Inc (SGMT)
According to the 24-hour chart, there is a support level at 4.26, which, if violated, would cause prices to drop to 4.02. In the upper region, resistance lies at 4.75. The next price resistance is at 5.00. RSI (Relative Strength Index) is 40.28 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.87, which suggests the price will decrease in the coming days. Percent R is at 85.97%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
